Welcome to our dedicated page for NextPlat news (Ticker: NXPL), a resource for investors and traders seeking the latest updates and insights on NextPlat stock.
NextPlat Corp (NASDAQ: NXPL, NXPLW) is frequently featured in corporate news for its activities in healthcare services, satellite-enabled communications and global e-commerce. The company describes itself as a global consumer products and services business that delivers healthcare and technology solutions through e-commerce and retail channels, and its announcements reflect developments across these areas.
News about NextPlat often covers its healthcare operations, including pharmacy services under the PharmcoRx brand, healthcare data analytics through its ClearMetrx subsidiary, and multi-state prescription fulfillment contracts. Recent updates have highlighted new healthcare contracts, expansion of 340B clinic services, and the planned launch of ClearMetrx 4.0, an artificial intelligence–powered healthcare analytics and reporting platform designed to support more efficient operations and improved patient adherence.
In the communications segment, NextPlat news includes developments at Global Telesat Communications Ltd and other subsidiaries that provide satellite-enabled voice, data, tracking and IoT products and services. The company has announced a distribution agreement with Telit Cinterion to add AI-powered 5G and edge computing solutions to its IoT portfolio, as well as commentary on growing transaction volumes and recurring airtime revenue related to satellite-based connectivity.
NextPlat’s e-commerce and consumer products activities also generate regular headlines. These include the launch of the Florida Sunshine brand of premium vitamins and supplements in the United States, the UK and Europe, and preparations for sales in China via Tmall Global, supported by an AI-powered digital advertising platform. Corporate governance and capital markets updates, such as leadership appointments, shareholder letters, conference call announcements and Nasdaq listing communications, are also common topics. Investors and observers can use this news stream to follow how NextPlat’s healthcare, communications and e-commerce initiatives evolve over time.
NextPlat (NASDAQ: NXPL) expects consolidated Q1 2026 gross margins >34%, driven by a shift to higher‑margin contracted healthcare services. The company forecasts Q1 Healthcare Operations revenue of about $6.7M (down from $9.6M in Q4 2025), an ~9% reduction in operating expenses, and targets positive operating income in Q3 2026. Cash of approximately $11M and working capital of about $14.3M were reported as of March 31, 2026.
NextPlat (NASDAQ: NXPL) announced it has regained compliance with Nasdaq's minimum bid price rule, Listing Rule 5550(a)(2), after Nasdaq confirmed the closing bid was at least $1.00 per share for 10 consecutive business days from April 13, 2026 to April 24, 2026.
Nasdaq sent a compliance letter dated April 27, 2026 and the matter is now closed; NextPlat remains listed on The Nasdaq Capital Market under the ticker NXPL.
NextPlat (NASDAQ: NXPL) said its PharmcoRx subsidiary has deployed AI-powered prescription in-take and processing technology into its pharmacy management system effective April 16, 2026. The tools automate data entry, faxing and refill management, create HIPAA-compliant digital workflows and support scaled fulfillment for new contracted clients.
NextPlat (NASDAQ: NXPL) said its Global Telesat Communications subsidiary received new satellite-enabled IoT orders of approximately $400,000, supporting a military end-user in Eastern Europe and a new customer in Asia. The orders follow a prior $820,000 contract for a NATO military customer.
Through Q1 2026, GTC's government and military IoT product orders totalled more than $1.2 million, which the company cites as momentum for 2026 growth alongside healthcare expansion.
NextPlat (NASDAQ: NXPL) announced a 1-for-10 reverse stock split effective at 12:01 AM ET on April 13, 2026. Every ten pre-split shares will be consolidated into one post-split share, reducing outstanding shares from approximately 26.9 million to approximately 2.7 million.
The company's common stock will open for trading on The Nasdaq Global Market on April 13, 2026 on a post-split basis under the existing ticker NXPL and a new CUSIP 68557F 308. Fractional shares will be settled for cash in lieu; authorized shares remain at 50 million and par value stays at $0.0001.
NextPlat (NASDAQ: NXPL) reported consolidated revenue of $54.3 million for 2025, down 18% year-over-year, driven by lower prescription volume. Healthcare revenue was $39.7 million and e-commerce revenue was $14.6 million. Gross margin declined to ~20% from 26% in 2024.
Operating expenses fell ~50% to $19.9 million; net loss attributable to common stockholders was $11.7 million or ($0.44) per diluted share. The company ended 2025 with ~$13.7 million cash, no meaningful unsecured debt, and ~$15.0 million working capital, and said cost-cutting and 340B/fulfillment focus will support 2026 profitability.
NextPlat (NASDAQ: NXPL) announced a 1-for-10 reverse stock split effective 12:01 a.m. ET on April 6, 2026, with split-adjusted trading to begin on Nasdaq on April 7, 2026 under the existing ticker NXPL.
The split will reduce outstanding shares from 27,026,215 to approximately 2,702,621, cashed-out fractional shares, will not reduce authorized shares, and aims to regain compliance with Nasdaq's minimum bid price requirement.
NextPlat (NASDAQ: NXPL) announced a collaboration with HealthWarehouse to enable nationwide prescription and OTC fulfillment to all 50 U.S. states, expanding PharmcoRx beyond Florida.
The agreement leverages HealthWarehouse's NABP‑accredited digital pharmacy and national fulfillment to support rapid e-commerce expansion and revenue growth in 2026.
NextPlat (NASDAQ: NXPL) will release full-year 2025 financial results on Tuesday, March 31, 2026. Management will host a conference call at 8:30 a.m. Eastern to discuss results and recent developments.
Investors must submit Q&A questions by March 27, 2026 to investors@nextplat.com. The live webcast and replay will be available via the company webcast link and the investor relations site; phone dial-in and replay numbers are provided.
NextPlat (NASDAQ: NXPL) announced that its Global Telesat Communications subsidiary was awarded a two-year contract worth up to $820,000 from a U.K. government prime supplier to supply satellite-enabled IoT hardware in support of a NATO military end user.
The program uses Iridium Certus dual-mode satellite and LTE terminals for voice, data, and asset management to enable resilient, global connectivity.